CanSino Biologics Inc. (HKG:6185)

CanSino Biologics Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,141	11,610	12,491	27,690	66,111	74,412
Market Cap Growth	40.34%	-7.06%	-54.89%	-58.12%	-11.15%	466.94%
Enterprise Value	9,266	10,302	10,588	23,868	58,920	68,404
Last Close Price	31.85	31.50	23.55	66.75	177.89	174.24
PE Ratio	-	-	-	-	28.13	-
Forward PE	140.37	-	-	-	11.16	25.30
PS Ratio	11.95	12.89	31.75	23.68	12.53	2517.38
PB Ratio	2.12	2.15	2.14	3.38	6.30	10.32
P/TBV Ratio	2.17	2.21	2.21	3.75	6.89	10.38
P/FCF Ratio	-	-	-	-	63.60	-
P/OCF Ratio	-	-	-	-	26.27	-
EV/Sales Ratio	9.94	11.44	26.92	20.41	11.16	2314.14
EV/EBITDA Ratio	-	-	-	-	25.96	-
EV/EBIT Ratio	-	-	-	-	26.91	-
EV/FCF Ratio	-	-	-	-	56.68	-
Debt / Equity Ratio	0.27	0.42	0.51	0.37	0.16	0.02
Debt / EBITDA Ratio	-	-	-	-	0.74	-
Debt / FCF Ratio	-	-	-	-	1.62	-
Asset Turnover	0.11	-	0.03	0.09	0.46	0.01
Inventory Turnover	-	-	1.55	1.57	2.48	0.16
Quick Ratio	2.42	-	1.86	2.33	2.78	12.54
Current Ratio	2.65	-	2.02	2.64	3.25	13.24
Return on Equity (ROE)	-4.31%	-7.32%	-31.40%	-12.22%	26.09%	-10.52%
Return on Assets (ROA)	-2.14%	-	-10.36%	-8.03%	11.97%	-7.58%
Return on Capital (ROIC)	-2.54%	-3.09%	-12.01%	-9.43%	13.82%	-8.24%
Return on Capital Employed (ROCE)	-	-	-	-	19.80%	-
Earnings Yield	-2.12%	-3.47%	-13.08%	-3.71%	3.55%	-0.63%
FCF Yield	-	-	-13.39%	-11.95%	1.57%	-1.02%
Dividend Yield	-	-	-	-	0.55%	-
Payout Ratio	-	-	-	-	0.74%	-
Buyback Yield / Dilution	1.38%	-0.38%	0.17%	0.08%	-7.26%	-11.79%
Total Shareholder Return	1.38%	-0.38%	0.17%	0.08%	-6.70%	-11.79%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.